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The Cronkhite–Canada syndrome (CCS) is a rare disorder of unknown origin charac-
terized by generalized gastrointestinal polyposis, alopecia, hyperpigmentation, and 
onychodystrophy. We report a case of CCS with concomitant presentation of mononeu-
ritis multiplex. The electrophysiological findings and steroid responsiveness suggests 
presence of an autoimmune mechanism.
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The Cronkhite–Canada syndrome (CCS) is a rare disorder of unknown origin characterized by gen-
eralized gastrointestinal polyposis, alopecia, hyperpigmentation, and onychodystrophy (1). Patients 
develop protein-losing enteropathy and progressive malnutrition. Neurological complications in 
CCS are seldom reported. To our knowledge, only one case report of peripheral neuropathy in asso-
ciation with CCS has been published (2). Here, we report an unusual case of CCS with concomitant 
presentation of mononeuritis multiplex (MM). Informed and written consent has been obtained 
from the patient for the purpose of this report.
Case RepoRt
A 71-year-old man with previous medical histories of hypertension, hemorrhoids, and glaucoma 
first presented with weight loss, hair loss, abdominal colic, altered taste, and diarrhea for a 4-month 
duration. He denied having melena, hemetemesis, or blood in his stools.
He also complained of having hypoesthesia and paresthesia in his hands and feet simultaneously 
6 months later. However, no pain, weakness, rashes, joint swelling, and fever were noted. His vision, 
speech, hearing, and smell sensation were unchanged.
Clinical examination revealed he was not jaundiced, pale, or cachectic. His abdomen was soft and 
not distended. There was no palpable hepatosplenomegaly or lymphadenopathy.
Neurological examination revealed mild motor weakness (4/5 on the MRC scale) of the finger 
abduction, ankle dorsiflexion, and plantar flexion, involving the left side more severely. However, 
deep tendon reflexes were diminished in both ankles and sensory testing revealed diminished touch 
and temperature sensation of both hands and feet. Vibration and position sense were intact. Gait and 
cerebellar system testing were normal.
Hematological investigations performed initially showed normal blood counts and electrolytes, 
but hypoalbuminemia (5 μmol/L) without transaminitis. Thyroid function, vitamin B12, and folate 
levels were unremarkable. Autoimmune tests, including antinuclear, anti-Smith, anti-smooth mus-
cle, Ro, La, ribonuclear protein, anti-double stranded DNA, and anti-Jo1 titers were not elevated. 
Hepatitis B and C serology were negative.
taBLe 2 | Motor NCs.
 NCs 1 NCs2
Nerve Latency (ms) amplitude (mV) Conduction velocity (m/s) Latency (ms) amplitude (mV) Conduction velocity (m/s)
L median motor 3.98 (<4.5) 5.9 (>5) 53.2 (>45) 3.28 7.7 51.0
R median motor 4.21 5.2 54.1 4.13 6.6 53.2
L ulnar motor 2.66 (<3.1) 3.4 (>6) 51.7(>45) 2.83 8.5 52.2
R ulnar motor 2.65 3.3 53.9 2.90 9.1 49.7
L tibial motor 4.37 (<5.5) 1.15 (>2) 38.3 (>38) 3.91 5.0 45.9
R tibial motor 5.21 2.1 41.3 4.04 10.1 44.7
L peroneal motor 4.43 (<4.8) 1.65 (>2) 35.6 (>38) 3.87 3.8 41.1
R peroneal motor 2.18 2.4 37.3 3.51 3.8 41.8
NCS, nerve conduction study; L, left; R: right; 1, first NCS; 2, second NCS (performed 2 years later).
Normal values indicated in brackets.
Abnormal values indicated in bold.
taBLe 1 | sensory NCs.
 NCs 1 NCs2
Nerve Latency (ms) amplitude (μV) Conduction velocity (m/s) Latency (ms) amplitude (μV) Conduction velocity (m/s)
L median sensory 2.85 (<3.9) 10.8 (>10) 45.6 (>45) 2.69 31.9 48.3
R median sensory 3.09 10.1 42.1 3.09 24.2 45.3
L ulnar sensory 2.38 (<3) 4.5 (>7) 46.2 (>45) 2.23 15.6 49.3
R ulnar sensory 2.30 3.3 47.8 2.34 15.7 51.3
L peroneal sensory 3.00 (<3.1) 0.89 (>4) 40.0 (>38) 2.55 6.4 45.1
R peroneal sensory 3.00 5.3 40.0 2.75 7.3 43.6
L sural sensory 2.92 (<3.8) 2.5 (>2.0) 41.1 (>38) 2.71 5.7 44.3
R sural sensory 3.00 1.9 40.0 2.22 5.2 45.0
NCS, nerve conduction study; L, left; R, right; 1, first NCS; 2, second NCS (performed 2 years later).
Normal values indicated in brackets.
Abnormal values indicated in bold.
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CT abdominal scan revealed few diverticula in the colon. CT 
colonoscopy, however, found extensive nodular appearance of the 
colonic mucosa and few polyps.
The patient underwent endoscopic examination, whereby 
gastroscopy showed infiltrative lesions in the stomach and 
duodenum, while colonoscopy detected multiple strawberry-
like hamartomatous polyps in the entire colon and occasional 
tubulovillous adenomas with low-grade dysplasia. Biopsies of 
the stomach, duodenum, and colon revealed regenerative and 
hyperplastic changes with prominent lamina propia odema and 
increased eosinophils.
In view of his neurological complaints, he underwent a nerve 
conduction study (NCS) which showed asymmetrically reduced 
left peroneal sensory, right sural sensory, left peroneal motor, and 
left tibial motor amplitudes (Tables 1 and 2). In addition, there was 
significant reduction of bilateral ulnar sensory and motor ampli-
tudes. Sympathetic skin responses were normal in all four limbs.
He was diagnosed with CCS based on the clinical picture 
and characteristic histological findings. He was given parenteral 
nutrition on initial diagnosis. Intravenous hydrocortisone of 
100 mg was administered four times a day, and maintenance oral 
prednisolone 50 mg daily was continued when neuropathy was 
diagnosed on NCS.
He experienced gradual improvement in gastrointestinal 
symptoms, taste, appetite, and body weight over a 2-year period. 
Oral corticosteroids were reduced gradually and azathioprine 
was added as a steroid-sparing agent. A repeat gastroscopy 
and colonoscopy revealed normalization of mucosal changes 
(Figures 1 and 2). The patient also reported reduction of sensory 
complaints and strength improvement in his limbs. Examination 
showed residual reduced ankle tendon reflexes and touch sensa-
tion in both soles.
A repeat NCS (Tables  1 and 2), 2  years from the initial, 
demonstrated significant improvement in the above mentioned 
sensory and motor nerve amplitudes of above 100%.
DIsCUssIoN
This report describes a CCS patient presenting with clinical and 
electrophysiological features of MM, which responded to steroid 
therapy in tandem with improvement of his gastrointestinal 
dysfunction. This simultaneous observation suggests that the 
neurological and gastrointestinal processes share a common 
pathophysiological process. The extensive investigations per-
formed render nutritional and metabolic factors unlikely causes 
for his neuropathy. As his neurological symptoms appeared way 
after parental nutrition was administered, vitamin deficiency as a 
cause of neuropathy, hence, was unlikely. The impressive response 
to steroid therapy also supports the hypothesis that CCS is an 
immune-mediated disease.
Mononeuritis multiplex denotes neuropathy of individual 
nerves not in a length-dependent or radicular pattern. Clinically, 
FIGURe 1 | (a) Pre-treatment colonic images showing multiple strawberry-like hamartomatous colonic polyps. (B) Post-treatment colonic images showing a single 
tubulovillous adenoma with low-grade dysplasia and resolution of previous hamartomatous polyps.
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FIGURe 2 | (a) Gastric biopsies taken at time of diagnosis. Numerous pieces from various parts of the stomach show similar features. On low (a – H&E, 2× 
magnification) and medium (b – H&E, 10× magnification) power views, tortuous hyperplastic glands with occasional mild branching and dilatation are identified. 
A different field (c – H&E, 10× magnification) demonstrates an area of prominent lamina propria edema with a mixed inflammatory cell infiltrate including eosinophils. 
(B) (a – H&E, 5× magnification) (b – H&E, 2× magnification): biopsies of colonic hamartomatous polyps taken a year after diagnosis. The crypts are tortuous, and 
some are cystically dilated secondary to inspissated mucin. The intervening lamina propria shows an infiltrate of predominantly mononuclear cells, as well as 
occasional hypertrophic strands of smooth muscle cells. (B) Shows a focus of low-grade dysplasia arising on the background of a hamartomatous polyp.
MM can present as asymmetrical, asynchronous sensory, and/or 
motor polyneuropathy involving two or more separate nerve in 
random patterns of distribution: bilaterally, distally, proximally, or 
combinations of these. Hence, it can also be termed as “multiple 
mononeuropathy,” and autoimmune, paraneneoplastic, and dia-
betic etiologies are often implicated (3, 4). Electrophysiologically, 
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NCS often shows an axonal neuropathy whereby side-to-side 
comparison show grossly asymmetric amplitudes (5), as in this 
patient. A previous study of non-systemic vasculitis reported 
that most patients exhibited a multifocal or asymmetric, distally 
accentuated pattern of involvement, particularly affecting the 
peroneal and ulnar nerves. NCS also showed predominantly 
axonal, asymmetric, sensorimotor polyneuropathy (6). Other 
investigators also reported similar findings (7, 8), and these are 
corroborated by the NCS of our patient. Normal sympathetic 
skin responses suggest that small fiber-mediated sudomotor 
sympathetic function is not affected in this CCS patient. In all, the 
electrophysiological features point to an underlying autoimmune 
process.
While the exact incidence of etiologies in a cohort of MM 
patients has not be studied, MM is the most common pattern 
of involvement in vasculitic neuropathy, to the extent that both 
terms are often used interchangeably. Indeed, for primary sys-
temic vasculitic neuropathy, up to 85% of cases with polyarteritis 
nodosa, 80% of cases with Churg-Strauss syndrome, and 40% of 
cases with Wegener’s granulomatosis have vasculitic neuropathy. 
However, in several other connective tissue diseases, such as 
mixed connective tissue disease and sarcoidosis, vasculitic neu-
ropathy occur at a much lower frequency (9).
The cause of CCS is unknown to date. Previously reported 
associations include systemic lupus erythematosus, scleroderma, 
hypothyroidism, vitiligo, antinuclear antibodies, and mast cell 
dysfunction (10), suggesting an autoimmune mechanism at play.
The option of a nerve biopsy was discussed with our patient. 
Overall, its yield is approximately 60% (8), and sampling 
error cannot be ruled out in view patchy involvement in MM. 
Henceforth, he declined initial biopsy and opted for immuno-
therapy, resulting in significant improvement. A previous case 
report (2) of a CCS with clinical and NCS features of CCS who 
underwent sural nerve biopsy did not reveal any specific features 
apart from reduced myelinated fibers. However, this patient did 
not receive steroid therapy but was treated with a high protein 
and caloric diet. The patient demised 5 months after diagnosis.
To date, various treatment of CCS reported include dietary 
intervention, antibiotics, and immunosuppression, including 
steroids (11–13). However, the rarity of this condition renders 
large-scale studies unrealistic. Our patient’s NCS findings of MM 
point to large fiber involvement with increased likelihood of an 
underlying autoimmune etiology whereby steroid therapy can be 
a reasonable option. In addition, CCS has been associated with 
vitiligo, lupus erythematosus, scleroderma, and hypothyroidism 
(10), all pointing to an immune-mediated process.
This is the first reported case of steroid responsive MM in the 
CCS and significant recovery with steroid therapy suggests an 
autoimmune process underlying this condition.
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